SIC
DTIL icon

Samalin Investment Counsel’s Precision BioSciences DTIL Stock Holding History

Samalin Investment Counsel’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,545
Closed -$59.2K – 322
2024
Q4 		$59.2K Buy
+15,545
New +$114K 0.03% 288

Other funds holding DTIL

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Samalin Investment Counsel's DTIL Position: Q1 2025 in Review

Samalin Investment Counsel sold out of Precision BioSciences (DTIL) in Q1 2025, closing a stake of 15,545 shares — an estimated $59.2K sold.

Samalin Investment Counsel first reported a position in DTIL in Q4 2024 and held it in 1 quarter. The position peaked at $59.2K in Q4 2024. 48 funds tracked by Wall St. Rank hold DTIL as of Q1 2025.

  • Samalin Investment Counsel reported no remaining Precision BioSciences position as of Q1 2025 after selling out during the quarter.
  • Samalin Investment Counsel sold 15,545 Precision BioSciences shares in Q1 2025, an estimated $59.2K.
  • Samalin Investment Counsel first reported a position in Precision BioSciences in Q4 2024 and held it in 1 quarter.
  • Samalin Investment Counsel's Precision BioSciences position peaked at $59.2K in Q4 2024.
  • 48 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2025.

Based on Samalin Investment Counsel's 13F filing for Q1 2025, filed 14 May 2025.